Lexeo Therapeutics (LXEO) Amortizatization of Intangibles (2022 - 2026)
Lexeo Therapeutics recorded quarterly Amortizatization of Intangibles of $80000.0 in Q1 2026, down 93.61% quarter-over-quarter from $1.3 million in Q4 2025, and down 77.84% year-over-year from $361000.0 in Q1 2025.
Lexeo Therapeutics' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $80000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 77.84% year-over-year to $80000.0; the TTM figure through Mar 2026 stood at $1.5 million (up 148.09% YoY), while the FY2025 annual figure was $1.5 million, up 358.77% from the prior year.
- Amortizatization of Intangibles came in at $80000.0 for Q1 2026 at Lexeo Therapeutics, down from $1.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q4 2025 to a low of -$626000.0 in Q4 2023.
- A 5-year average of $144400.0 and a median of $80000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles slumped 795.56% in 2023 and jumped 1463.75% in 2025, its largest moves.
- Lexeo Therapeutics' Amortizatization of Intangibles stood at $90000.0 in 2022, then plunged by 795.56% to -$626000.0 in 2023, then jumped by 112.78% to $80000.0 in 2024, then surged by 1463.75% to $1.3 million in 2025, then slumped by 93.61% to $80000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $80000.0, $1.3 million, and $80000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | 80,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80,000.00 |
| Mar 31, 2026 | 80,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 80,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2023 | -626,000.00 |
| Dec 31, 2023 | -626,000.00 |
| Sep 30, 2023 | 79,000.00 |
| Sep 30, 2023 | 79,000.00 |
| Jun 30, 2023 | 79,000.00 |
| Jun 30, 2023 | 79,000.00 |
| Mar 31, 2023 | 321,000.00 |
| Mar 31, 2023 | 321,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 46,000.00 |
| Sep 30, 2022 | 46,000.00 |